Channing Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.22M Buy
31,493
+1,919
+6% +$631K 0.24% 72
2025
Q4
$10.4M Sell
29,574
-6,475
-18% -$2.19M 0.27% 61
2025
Q3
$11.6M Buy
36,049
+8,861
+33% +$2.76M 0.31% 58
2025
Q2
$10.6M Buy
27,188
+2,557
+10% +$1.03M 0.29% 58
2025
Q1
$10.7M Buy
24,631
+12
+0% +$4.82K 0.32% 51
2024
Q4
$9.08M Buy
+24,619
New +$10.3M 0.24% 73
2021
Q3
Sell
-6,318
Closed -$2.41M 114
2021
Q2
$2.41M Sell
6,318
-14,443
-70% -$5.52M 0.08% 112
2021
Q1
$7.45M Buy
20,761
+7,517
+57% +$2.42M 0.25% 97
2020
Q4
$4.25M Sell
13,244
-6,123
-32% -$1.88M 0.17% 98
2020
Q3
$5.2M Sell
19,367
-2,601
-12% -$700K 0.28% 89
2020
Q2
$5.78M Sell
21,968
-2,751
-11% -$734K 0.33% 78
2020
Q1
$5.61M Sell
24,719
-4,541
-16% -$1.24M 0.4% 64
2019
Q4
$8.84M Sell
29,260
-3,747
-11% -$1.03M 0.41% 70
2019
Q3
$7.92M Buy
33,007
+3,495
+12% +$958K 0.37% 75
2019
Q2
$8.33M Buy
29,512
+17,795
+152% +$4.86M 0.39% 66
2019
Q1
$3.36M Buy
+11,717
New +$3.39M 0.16% 93

Other funds holding ELV

Channing Capital Management's ELV Position: Q1 2026 in Review

Channing Capital Management increased its Elevance Health (ELV) stake by 6.5% in Q1 2026, buying an estimated $631K and bringing the position to 31,493 shares worth $9.22M. The position accounts for 0.24% of the portfolio, ranked #72.

Channing Capital Management first reported a position in ELV in Q1 2019 and has held it in 16 quarters since. The position peaked at $11.6M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Channing Capital Management held 31,493 shares of Elevance Health worth $9.22M as of Q1 2026.
  • Channing Capital Management bought 1,919 Elevance Health shares in Q1 2026, an estimated $631K.
  • Elevance Health made up 0.24% of Channing Capital Management's portfolio in Q1 2026, its #72 holding.
  • Channing Capital Management first reported a position in Elevance Health in Q1 2019 and has held it in 16 quarters since.
  • Channing Capital Management's Elevance Health position peaked at $11.6M in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Channing Capital Management's 13F filing for Q1 2026, filed 14 May 2026.